PERRIGO CO PLC (PRGO)
IE00BGH1M568 - Common Stock
Taking everything into account, PRGO scores 4 out of 10 in our fundamental rating. PRGO was compared to 198 industry peers in the Pharmaceuticals industry. PRGO has a medium profitability rating, but doesn't score so well on its financial health evaluation. PRGO has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PRGO was profitable.
In the past year PRGO had a positive cash flow from operations.
PRGO had negative earnings in 4 of the past 5 years.
PRGO had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of -0.12%, PRGO belongs to the best of the industry, outperforming 81.12% of the companies in the same industry.
The Return On Equity of PRGO (-0.27%) is better than 82.65% of its industry peers.
With an excellent Return On Invested Capital value of 2.43%, PRGO belongs to the best of the industry, outperforming 80.61% of the companies in the same industry.
PRGO had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 16.40%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.12% | ||
| ROE | -0.27% | ||
| ROIC | 2.43% |
ROA(3y)-0.68%
ROA(5y)-0.44%
ROE(3y)-1.5%
ROE(5y)-0.97%
ROIC(3y)3.16%
ROIC(5y)2.69%
1.3 Margins
PRGO has a Operating Margin of 6.10%. This is in the better half of the industry: PRGO outperforms 79.08% of its industry peers.
In the last couple of years the Operating Margin of PRGO has declined.
PRGO has a Gross Margin (36.09%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of PRGO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | N/A | ||
| GM | 36.09% |
OM growth 3Y-2.94%
OM growth 5Y-9.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.43%
GM growth 5Y-1.39%
2. Health
2.1 Basic Checks
PRGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PRGO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PRGO has been reduced compared to 5 years ago.
The debt/assets ratio for PRGO is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.79, we must say that PRGO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PRGO (0.79) is comparable to the rest of the industry.
The Debt to FCF ratio of PRGO is 13.41, which is on the high side as it means it would take PRGO, 13.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PRGO (13.41) is better than 81.12% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that PRGO is somewhat dependend on debt financing.
PRGO has a Debt to Equity ratio of 0.76. This is in the lower half of the industry: PRGO underperforms 68.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 13.41 | ||
| Altman-Z | 0.79 |
ROIC/WACC0.36
WACC6.84%
2.3 Liquidity
A Current Ratio of 1.79 indicates that PRGO should not have too much problems paying its short term obligations.
PRGO has a worse Current ratio (1.79) than 70.41% of its industry peers.
A Quick Ratio of 1.07 indicates that PRGO should not have too much problems paying its short term obligations.
PRGO has a worse Quick ratio (1.07) than 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
PRGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.64%, which is quite impressive.
The earnings per share for PRGO have been decreasing by -10.69% on average. This is quite bad
Looking at the last year, PRGO shows a small growth in Revenue. The Revenue has grown by 4.58% in the last year.
The Revenue has been decreasing by -0.32% on average over the past years.
EPS 1Y (TTM)24.64%
EPS 3Y-14.79%
EPS 5Y-10.69%
EPS growth Q2Q14.67%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y4.43%
Revenue growth 5Y-0.32%
Revenue growth Q2Q0.14%
3.2 Future
The Earnings Per Share is expected to grow by 14.14% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.57% on average over the next years.
EPS Next Y-7.17%
EPS Next 2Y7.59%
EPS Next 3Y8.04%
EPS Next 5Y14.14%
Revenue Next Year-0.34%
Revenue Next 2Y2.09%
Revenue Next 3Y2.65%
Revenue Next 5Y3.57%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.94, which indicates a very decent valuation of PRGO.
PRGO's Price/Earnings ratio is rather cheap when compared to the industry. PRGO is cheaper than 90.31% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.76, PRGO is valued rather cheaply.
A Price/Forward Earnings ratio of 12.86 indicates a correct valuation of PRGO.
88.27% of the companies in the same industry are more expensive than PRGO, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.26. PRGO is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.94 | ||
| Fwd PE | 12.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PRGO is valued cheaply inside the industry as 83.16% of the companies are valued more expensively.
88.27% of the companies in the same industry are more expensive than PRGO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.74 | ||
| EV/EBITDA | 11.47 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.59%
EPS Next 3Y8.04%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.53%, PRGO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.36, PRGO pays a better dividend. On top of this PRGO pays more dividend than 93.88% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, PRGO pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.53% |
5.2 History
The dividend of PRGO is nicely growing with an annual growth rate of 7.88%!
PRGO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.88%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PRGO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of PRGO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-1178.74%
EPS Next 2Y7.59%
EPS Next 3Y8.04%
PERRIGO CO PLC
NYSE:PRGO (4/19/2024, 7:11:09 PM)
After market: 30.45 -0.35 (-1.14%)30.8
+0.86 (+2.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.17B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.53% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.94 | ||
| Fwd PE | 12.86 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.12% | ||
| ROE | -0.27% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 6.1% | ||
| PM (TTM) | N/A | ||
| GM | 36.09% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)24.64%
EPS 3Y-14.79%
EPS 5Y
EPS growth Q2Q
EPS Next Y-7.17%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.58%
Revenue growth 3Y4.43%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y